Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
88 participants
INTERVENTIONAL
2012-08-31
2018-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ambulatory Blood Pressure and Behavior
NCT00005170
Improving Care for Patients With High Blood Pressure
NCT01425515
Blood Pressure (BP) Visit Intensification Study
NCT02164331
Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers
NCT00113074
Using Nonpharmacological Approaches in Hypertension Prevention and Management
NCT06490575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participation is completely voluntary and confidential. Volunteers completing each of the phases will be compensated $100 for their time. If someone is interested in participating, they should call our office at 850-645-0247 or email [email protected].
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhancing willpower using active skills
This group will use active tasks such as learning skills using hands to enhance willpower.
Self-Care Training
Enhancing willpower using passive tasks
This group will use passive tasks such as taking still postures to enhance willpower.
Self-Care Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-Care Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 25 or older
Exclusion Criteria
* Participation in other clinical trials or drug/behavioral treatment
* Previously participated in any other clinical trials/training on health-related behavior (tai-chi, yoga, nutritional education, yoga class)
* Kidney disease
* Cancer/chemotherapy, advanced HIV/AIDS, severe liver disease
* Severe ischemic heart disease (unstable angina, hospitalization for heart attack, coronary revascularization)
* Congestive heart failure
* Severe inflammatory/rheumatologic disorders (severe arthritis)
* Severe mental health diagnosis such as schizophrenia or bi-polar disorder
* Occurrence of any neurological disorders such as stroke or dementia
* Addicted to any legal/illegal drugs or alcohol without at least 1 year of sobriety
* Any infectious conditions such as pneumonia, traumatic wound, or surgery that may cause inflammation in the past 14 days
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Florida State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy L Ai, PhD
Role: PRINCIPAL_INVESTIGATOR
Florida State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FSU College of Social Work
Tallahassee, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FSU-2012.8601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.